Abstract Hospital-acquired pneumonia (HAP) is the most frequent hospital-acquired infection in critically ill patients. National Nosocomial Infections Surveillance (NNIS) system reported that HAP accounts for as much as 31% of all nosocomial infections acquired in medical intensive care units (ICU). The increasing incidence of infections caused by antibiotic-resistant pathogens contributes to a high mortality rate, longer ICU stay and higher costs. In this study, we aimed to identify the incidence of HAP, the associated risk factors, and its effect on outcome. We evaluated as well the usefulness of multiplex polymerase chain reaction (m-PCR) as a novel tool for emergency diagnosis of HAP.
Introduction
Several reports published recently confirm that hospital-acquired pneumonia (HAP) remains to be a major medical problem in most European countries, and in the United States despite the advances in the quality of patient care, availability of effective antibiotics, complex technological diagnostic facilities and awareness in infection control measures [1] . Its occurrence represents additional cost, morbidity and most importantly, mortality among patients hospitalized initially for other reasons. The reported frequency varies with the definition, type of ICU, patients' population, and antibiotic policies [2] .
Etiologic diagnosis of HAP is considered a microbiological emergency because of its impact on disease associated morbidity and mortality and antibiotic management, so rapid diagnostic information is clearly more beneficial to patients than more complete but delayed information. Multiplex-PCR is a universal technique making it possible to identify more than one micro-organism, in less than one hour directly from patient specimens making it very specific and time-saving for diagnosis [3, 4] .
The Egyptian data on HAP are lacking. The aim of this study was to determine the incidence of hospital-acquired pneumonia, to identify risk factors associated with its development, and describe its effect on hospital stay and mortality in critically ill patients. Also in our study, we aimed to evaluate the usefulness of m-PCR as an emergency tool for the diagnosis of HAP compared to bacterial culture.
Patients and methods

Study setting
This study was conducted in pediatric intensive care unit (PICU) of Ain Shams University Hospital, which is a multidisciplinary medical ICU with 10 beds and average occupancy rate of 80% during the time of the study.
Patients' data acquisition
Demographic variables such as gender, age, underlying disease together with the patients' clinical data, degree of critical illness by PELOD score [5] , risk factors of pneumonia, length of PICU stay, duration of mechanical ventilation, and antibiotic regimen were collected from patients' records after getting the parents' consent and the approval of ethical committee. Data collection began within 24 h from the time of admission to the ICU and continued until the diagnosis of HAP was made or until the third day after the transfer out of the PICU.
Patients' enrollment
All admitted patients were observed daily for the diagnosis of HAP according to The Clinical Pulmonary Infection Score (CPIS). [6] . criteria for the diagnosis of nosocomial pneumonia, taking into account clinical factors, such as fever and leukocytosis, as well as radiological criteria, including persistent new findings on chest radiograph (Box 1) [6] .
We used the Clinical Pulmonary Infection Score (CPIS) to help quantify clinical findings and represent a ''weighted approach'' to the clinical diagnosis of HAP. This scoring system includes both clinical and radiological factors that increase the likelihood of the presence of nosocomial pneumonia. Point values are assigned to each criteria and a sum is calculated. Traditionally, a threshold score of more than six has been used to diagnose pneumonia (Table 1 ) [7] .
Microbiological assessment
Clinical specimens
Both endotracheal aspirate (ETA) and blood samples were screened from enrolled patients. These specimens were tested against important and common bacterial pathogens by both bacterial culture and multiplex Polymerase Chain Reaction (m-PCR).
Bacterial cultures
Specimens were obtained and sent to the laboratory within one hour of collection. They were decontaminated and centrifuged before inoculation. Inoculation was on blood agar and chocolate agar for blood specimens and further on McConkey agar for ETA. Specimens were incubated for one week and observed for colonies every day in ETA and every 48 h in blood specimens. Colonies were identified by gram stain and biochemical profile. Infection was defined by semi-quantitative count of more than 10 5 CFU/ml. Antibiotic sensitivity test was done for positive isolates using disk diffusion method according to the National Committee for clinical Laboratory standards (NCCLS) Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disc susceptibility test: Approved standard-Ninth edition (200).
Multiplex PCR
Collected specimens were assessed for seven bacterial agents; that are considered serious causative pathogens for HAP worldwide. These organisms are sharing some physical properties during their processing for PCR (Acinetobacter was not involved in the panel because it has different incubation temperature than the selected primers for the other seven organisms). DNA extraction: DNA was extracted from the samples using MagNA pure Compact Nucleic Acid Isolation Kit I (Cat. No. o3730964001); supplied by (Roche, Germany). Amplification by PCR: This was done by Light Cycler-DNA Amplification Kit SYBR Green I (Cat. No. 2015137). The kit used Light Cycler 2.0 System (Roche, Germany). Primers: Primers were non-labeled forward primers and biotin-labeled reverse primers with horseradish peroxidase-labeled probes. Primers for Mycoplasma pneumoniae, Chlamydiapneumoniae, Legionella pneumophilia, Staphylococcus aureus, and Streptococcus pneumoniae were selected according to Kumar et al. [8] . Primers for Klebsiella pneumoniae were made according to Kurupati et al. [9] . Primers for Pseudomonas aeruginosa were chosen according to Qin et al. [10] .
Statistical analysis
Analysis of data was done by IBM computer using SPSS 12-USA. Description of quantitative variables is expressed as mean and standard deviation (SD). Description of qualitative variables is expressed as number and percentage. The Wilcoxon's signed-rank test compared the difference between culture and PCR in different study specimens. There is no gold standard for the diagnosis of VAP or HAP in pediatric patients; therefore, we used a clinical definition of HAP based on Clinical Pulmonary Infection Score of NNIS (National Nosocomial Infections Surveillance) age-specific guidelines. Sensitivity and specificity of m-PCR and bacterial culture were referred to CPIS as the clinical gold standard for the diagnosis of HAP (CPIS P 6 is the cut-off for diagnosis of HAP) [7] .
Sensitivity of culture or m-PCR represents the proportion of patients with HAP who were test positive. Specificity is Adapted from Swoboda et al. [7] . the proportion of patients without HAP who were test negative. Predictive value of a positive test (PPV) is the proportion of patients with positive tests who have disease. Predictive value of a negative test (NPV) is the proportion of patients with negative tests who do not have disease.
Results
Patients' cohort characteristics
Ninety patients were admitted to the PICU during the study period with mean age 21 ± 18.7 months, and males represented 49% of them. Their median PELOD score was 24 with predicted mortality rate of 34%. Almost half of admitted cases were admitted due to neurological emergency (coma and acute flaccid paralysis). Twenty-five patients developed HAP after 72 h of admission according to CPIS score. Nineteen patients out of 25 had ventilator-associated pneumonia (VAP) (76%). The recorded rate of HAP during the period of study was 13 cases per 1000 patient-days. Forty-four percent of patients with HAP were less than 12 months, and 76% of them were males. The distribution of the primary cause of PICU admission did not differ significantly between patients who acquired HAP and those who did not (Table 2) .
Hospital-acquired pneumonia and its risk factors
Univariate analysis of different risk factors for the development of HAP in our study revealed that mechanical ventilation (OR: 10; 95% CI: 3.2-30; p < 0.001), re-intubation (OR: 8.7; 95% CI: 2.3-31.5; p < 0.001), sedation by benzodiazipins and opioids (OR: 4.3; 95% CI: 1.6-11.7; p < 0.01), nasogastric feeding (OR: 7.1; 95% CI: 2.6-19.6; p < 0.001), gastro-esophageal reflux (OR: 10.3; 95% CI: 3.1-33.6; p < 0.001), and H 2 Blockers (OR: 9.6; 95% CI: 2.14-45.3; p < 0.001) were significant risk factors for acquiring HAP (Table 3) .
Clinical outcomes of hospital-associated pneumonia
Length of PICU stay was doubled in patients who acquired HAP compared to patients without HAP (p < 0.05). Duration of mechanical ventilation was significantly longer in patients with HAP (p < 0.01). HAP lead to 10% increment in the actual mortality rate above the predicted rate for the affected patients with significant higher mortality than patients without HAP (Table 2) .
Etiologic diagnosis of HAP by multiplex-PCR and bacterial culture
In our study, multiplex-PCR had a better diagnostic yield for HAP than bacterial culture (sensitivity 76%, specificity 97%, PPV 90%, NPV 93% vs. 24%, 92%, 55%, 79%, respectively, for culture).
Acinetobacter was the most frequent organism isolated by culture followed by K. pneumoniae and P. aeruginosa (Table  4) . Multiplex-PCR significantly increased the diagnostic yield of MRSA, K. pneumonia, Streptococcus pneumoniae and M. pneumoniae. Polymicrobial pneumonia was diagnosed in two patients, where a combined growth of MRSA and Acinetobacter was present in one patient and combined growth of P. aeruginosa and K. pneumonia in another patient.
Discussion
Both developed and resource-poor countries are faced with the burden of health care-associated infections. In a World Health Organization (WHO) cooperative study involving 55 hospitals in 14 countries from four WHO regions, about 8.7% of hospitalized patients had nosocomial infections; among and represents the second most common nosocomial infection is HAP [11] . The frequency of hospital-acquired pneumonia in our PICU during study period was 13 per 1000 patient-days with associated mortality rate of 56% with predominance of Gram-negative pathogens; K. pneumoniae was diagnosed in 40%, Acinetobacter in 28% with MRSA in 24%. A 6-year surveillance study from 2002 to 2007 involving intensive care units in Latin America, Asia, Africa, and Europe, using Center for Disease Control's NNIS definitions, revealed higher rates of HAP and VAP than those of comparable United States ICUs. The survey also reported higher frequencies of mortalities associated with MRSA, Enterobacter species, and P. aeruginosa [12] . Patra et al. [13] reported that VAP constituted 76% of patients with hospital-acquired pneumonia and represented the most frequent nosocomial infection in intensive care units (80%) with an overall mortality of nosocomial pneumonia reaching 60%; all were secondary to Gram-negative infections with Pseudomonas contributing to 57.1% of deaths followed by Klebsiella, Escherichia coli and Acinetobacter. The increasing incidence of infections caused by antibiotic-resistant pathogens contributes to the emerging seriousness of these infections with expected higher mortality rate. Numerous studies have demonstrated that severe underlying illness predisposes patients in the ICU to the development of pneumonia and contribute to the associated high mortality rates [14] . In our study; the mean length of stay was doubled following HAP together with 50% increment in the mean duration of mechanical ventilation days. In another study, HAP lengthens the hospital stay by 7-9 days and is associated with a higher cost of medical care [14] . Fifty-two percent of enrolled patients with HAP in our study were admitted primarily to the PICU due to neurological emergencies (e.g. acute flaccid paralysis with rapid progression to involve respiratory muscles, status epileptics and coma). This group of patients had major neuro-critical dependency during their stay due to muscle paralysis. In Chiang Mai University Hospital, a tertiary care center, the most common indication for PICU admission was respiratory failure [15] , while in a tertiary teaching hospital in southern Brazil, bronchiolitis was reported to be the most frequent cause for PICU admission (77.6%) [16] . It is noted in our study that 44% of patients acquired HAP were less than 12 months and this may be explained by the vulnerability of this age group to life-threatening diseases. Seventy-six percent of them were males while females represent 24%, which raised the question of whether males are more susceptible to progression of illness and more vulnerable to critical illness. The same finding was noted by a study done by Khaled Amro [17] , in a referral hospital of South Jordan where 34.4% of enrolled patients 
# Acinetobacter is not involved in the m-PCR panel. with nosocomial pneumonia were less than one year age. Boys represent 57% of total number of patients enrolled by Srinivasan et al. [18] in a tertiary pediatric care center. Another study done by Martinbiancho et al. [19] also recorded a higher incidence of HAP among (males 63%). Many risk factors may favor or contribute to the development of nosocomial pneumonia. In our study, gastro-esophageal reflux disease (GERD) and treatment with H 2 Blockers, mechanical ventilation, nasogastric tube feeding, and use of benzodiazepines and opioids as sedative drugs, and re-intubation were significant risk factors for HAP. The primary route through which organisms enter the lower airways is via aspiration of colonized oropharyngeal secretions [19] . Micro-aspiration plays a central role in the pathogenesis of nosocomial pneumonia among critically ill patients especially those with nasogastric feeding and on mechanical ventilation (MV). The oropharynx of hospitalized patients becomes colonized with aerobic gram-negative bacteria within few days of admission. Therefore, nosocomial pneumonia is caused predominantly by the Gram-negative bacilli [20] . Within 12 h of intubation; a biofilm is formed around the endotracheal tube which contains large amounts of bacteria that can be disseminated into the lungs by ventilator-induced breaths. This biofilm may become dislodged during suctioning, or repositioning of the endotracheal tube [21] . Impaired muco-ciliary clearance with mucosal injury and glottic dysfunction associated with prolonged intubation further aggravates the risk of VAP with re-intubation [12] . Daily interruption of sedative infusions in critically ill patients receiving mechanical ventilation decreases the duration of mechanical ventilation and reduces the length of ICU stay. Consequently, this practice can be considered worthy for reducing VAP risk and its occurrence [21] [22] .
The causative organisms vary according to the patients' medical condition, demographics, methods of diagnosis, the durations of hospital and ICU stays, the antibiotic policy and the prior exposure to antimicrobials. All these factors significantly influence the distribution patterns of etiologic agents from one ICU to another [23] . The most frequent organisms detected in our study were K. pneumoniae (40%), Acinetobacter (28%) and followed by M. pneumoniae (24%) and MRSA (24%), while the least common isolates were Streptococcus pneumoniae (8%) and C. pneumoniae (4%).
Acinetobacter baumannii is now recognized to be capable of causing life-threatening infections including pneumonia [24] . This appears to be due to their ability to survive on health-care workers' hands and environmental surfaces and their intrinsic resistance to many common antibiotics, rather than any intrinsic virulence factors [25] . Antibiotic therapy and critical illness can suppress the normal bacterial flora and lead to an overgrowth of Enterobacteriaceae like K. pneumoniae in the respiratory tracts. The most concerning is the acquisition of extended-spectrum b-lactamases that render the bacteria resistant to penicillin and cephalosporin antibiotics [26] . Extended spectrum b-lactamase (ESBL) producing K. pneumoniae may cause serious nosocomial infections especially in critically ill patients. Numerous outbreaks have been described with ICU-acquired ESBL-producing K. pneumoniae where infection increased from a baseline rate of 0.44 cases per 1000 patientdays to 6.86 cases per 1000 patient-days [26] .
Streptococcus pneumoniae was not a common finding in our study because it predominates in the early days after intubation and is rapidly cleared after beginning antibiotic therapy as the isolates remain susceptible to achievable concentrations of traditional lactam antibiotics [27] . MRSA was detected as a causative agent for HAP in 24% of cases in our study by m-PCR. Staphylococcus aureus (both Methicillin sensitive and resistant strains), constitutes the most frequently isolated pathogen in the ICU. The incidence of MRSA as a cause of VAP was 12-15%, but increased to approximately 30% in patients with prolonged mechanical ventilation and prior antibiotic therapy [28] . Methicillin resistance in Staphylococcus aureus has the particularity to add multiple antimicrobial resistances up to 80% of macrolide resistance and 90% of quinolone resistance [29] . Those strains with mecA are resistant to all commercially available b-lactams, with considerable country-to-country variability [29] . Traditionally, we are not used to find M. pneumoniae in our bacteriological cultures as a causative pathogen of HAP, but in this study it was detected in 24% of patients and diagnosed only by m-PCR. Since that, we considered M. pneumoniae in the etiologic diagnosis of HAP in critically ill patients who develop nosocomial pneumonia within the first week after intubation [12, 28, 29] , and our therapeutic regimen should include these findings. Altogether with VAP task forces, the emergence of resistance is a concern for intensive care specialists worldwide thus it is imperative for investigators from different countries and regions to exchange precise and updated epidemiological data on the encountered HAP and VAP.
In our study, m-PCR optimized the diagnosis and management of hospital-acquired pneumonia over bacterial culture. The use of PCR leads to an increase in diagnostic sensitivity, especially in micro-organisms that cannot be easily cultured and in case of a low burden of micro-organisms with previous antibiotic therapy [30] . This is in agreement with Stra˚lin et al. [31] , who recommended multiplex PCR to be a useful etiological diagnostic tool in lower respiratory tract infection patients, particularly in those treated with antibiotics. The same was suggested early by Hendolin et al. [32] where multiplex PCR method improved the rapid and simultaneous detection rate of four bacterial pathogens in upper respiratory tract infections significantly compared to that of the conventional culture method.
Conclusion
Our study is one of the few prospective observational studies in critically ill children describing the risk factors and outcomes of hospital-acquired pneumonia. We found that gastro-esophageal reflux, treatment with H 2 blockers, mechanical ventilation, nasogastric feeding, use of sedative drugs and re-intubation are significant risk factors for HAP in our setting. These findings need to be confirmed in larger, multicenter studies to clarify risk factors and the impact of prevention strategies. Our study shows that HAP negatively impacts clinical and economic outcomes in critically ill pediatric patients by prolonging the length of mechanical ventilation and ICU stay and may increase total hospital charges and absolute hospital mortality rate. Moreover, m-PCR optimized the emergency diagnosis of hospitalacquired pneumonia over bacterial culture, especially in micro-organisms that cannot be easily cultured. Though the bacterial pattern of HAP in our study may differ from other countries, it is imperative for investigators from different regions to exchange precise and updated epidemiological data about HAP concerns.
